ArticleFrontiers in immunology2026

Dual-functioning Targeted ADAM17 Blocker CD16 (TAB16) mediates selective ADAM17 inhibition in NK cells and engages overexpressed ADAM17 in tumor cells to induce cytotoxicity.

Kate J Dixon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.